Role of guanylate cyclase modulators in decompensated heart failure.
about
Insights into Soluble Guanylyl Cyclase Activation Derived from Improved Heme-MimeticsSystems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General CasePotential new drug treatments for congestive heart failure.Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies.cGMP Signaling, Phosphodiesterases and Major Depressive Disorder.The current and future management of acute heart failure syndromes.Can we prevent or treat renal dysfunction in acute heart failure?Novel therapeutic targets for the treatment of heart failure.Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.Natriuretic peptides in therapy for decompensated heart failure.Novel vasodilators in heart failure.Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?Agents with vasodilator properties in acute heart failure.Update on the Management of Acute Decompensated Heart Failure.Influence of cinaciguat on gastrointestinal motility in apo-sGC mice.
P2860
Q27680135-9D35517F-0C59-444F-81CE-B40AE271F561Q28550867-141EBD9C-9686-42EC-93A5-CCD354F8E675Q30251531-FA9C7EB9-E616-45F3-9671-AECAF5557310Q35010064-882AA271-F810-4D4E-94C0-73D5743E160DQ35203569-4F96C2BD-AE5F-4F1E-BF7D-C674C08F75FFQ35687052-A139E3A3-5FD6-4766-8663-BE3AD975A643Q37703984-66365582-244E-4300-ADF9-AEC3022DE82DQ37873812-88177C19-E609-4945-A6D4-DCE7BDE45D8BQ37893956-DD4DC834-356D-40D0-8ADD-E2486E9311F3Q37900203-E980A471-ECAD-4057-9114-3EC972C86CBFQ37928970-0DD0DB8E-0320-41FA-973F-2D424F925401Q38072635-ED11C71E-3572-4F08-808D-899E9068C981Q38509576-51DE2765-6195-426F-BC1F-C2E950D46E79Q38818645-138061AF-94AC-4E33-9552-879C863C34D2Q38959942-74CE7185-3835-4C58-A7B0-83D736EC817CQ39258163-548BEAC1-382E-4B7E-A6D6-09405C5DB8D4Q49047822-BAAE28C8-D1B4-4818-A77D-2071458675D5
P2860
Role of guanylate cyclase modulators in decompensated heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of guanylate cyclase modulators in decompensated heart failure.
@en
Role of guanylate cyclase modulators in decompensated heart failure.
@nl
type
label
Role of guanylate cyclase modulators in decompensated heart failure.
@en
Role of guanylate cyclase modulators in decompensated heart failure.
@nl
prefLabel
Role of guanylate cyclase modulators in decompensated heart failure.
@en
Role of guanylate cyclase modulators in decompensated heart failure.
@nl
P2093
P2860
P1476
Role of guanylate cyclase modulators in decompensated heart failure.
@en
P2093
Adrian F Hernandez
Markus Meyer
Veselin Mitrovic
P2860
P2888
P304
P356
10.1007/S10741-009-9149-7
P577
2009-12-01T00:00:00Z